Furthermore, activation of the PI3K/AKT signaling pathway can induce the expression of glucose transporters GLUT1 and GLUT4, leading to an increased rate of glucose uptake in cancer cells (Melstrom et al., 2008; Park et al., 2020). Here, SLC2A1 is linked to cancer.